Five-year clinical outcomes of sirolimus
β
K. Anette Birkmeier; Adnan Kastrati; Robert A. Byrne; Heidrun Holle; Stefanie Sc
π
Article
π
2011
π
John Wiley and Sons
π
English
β 336 KB
π 2 views
## Abstract Objectives and Background: First generation drugβeluting stents have shown differential efficacy in highβrisk patient subsets at one year. It is unclear whether these differences endure over the mediumβ to longβterm. We compared the fiveβyear clinical efficacy and safety of sirolimusβel